Australian Prescriber

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

back pain

non-pharmacological management 17(2) 33-6

letters 18(1) 4-7; 18(1) 4-7

baclofen

new formulation - Lioresal Intrathecal 19(2) 38-40

bacteraemia

infection control and intravenous catheters 26(2) 41-3

letter 26(4) 75-7

bacteriuria

management of childhood urinary tract infections 22(2) 40-3

Bactroban

see mupirocin 21(4) 108-11

balsalazide

Colazide - ulcerative colitis (New drug) 28(4) 104-6

letter 29(2) 32-5

Baraclude

see entecavir 29(5) 138-43

barium meals

vs endoscopy in acid peptide disease (letter) 19(3) 59-62

basal cell carcinoma

methyl-5-aminolevulinate - Metvix (New drug) 27(3) 76-9

basiliximab

kidney transplantation - Simulect (New drug) 22(4) 95-8

Bayes' theorem

interpreting diagnostic tests 26(5) 111-13

BCG vaccination

tuberculosis 26(6) 144-6; 26(6) 146

letters 27(2) 28-33

beclomethasone dipropionate

asthma - Qvar - (New formulation) 23(3) 64-7

corticosteroid therapy in asthma 29(3) 63-6

behaviour disorders

attention deficit hyperactivity disorder 18(3) 60-3

atomoxetine - Strattera (New drug) 27(4) 101-5

letters 19(3) 59-62; 19(2) 36-8; 19(1) 3-6

methylphenidate (PBAC question) 24(5) 119

management of dementia 28(3) 67-70

psychotropic drugs for children in general practice 28(5) 116-8

risperidone in dementia (RADAR comment) 28(3) 71

behavioural therapy

management of childhood obesity 26(2) 30-2

Benefix

see recombinant factor IX 24(3) 71-5

benserazide/levodopa combination

Madopar (New formulation) 21(2) 49-55

benzene hexachloride

see lindane 21(1) 5-8; 20(2) 31-2

benzodiazepines

distribution in human milk 20(2) 35-40

drug-seeking behaviour 20(3) 68-70

dental implications 20(3) 61-4

insomnia 26(4) 78-81

letter 26(6) 124-5

interactions with antidepressants, neuroleptics and hypnotics 20(1) 5-8

management of withdrawal (letters) 18(3) 56-7; 17(4) 79-81

panic disorder 23(6) 124-6

letters 24(2) 27-8

patient support organisations 23(6) 128

personal experience 23(6) 127-8

repeat prescriptions (PBAC question) 21(1) 19

letter 21(3) 60-3

temazepam capsules and injecting drug users 27(3) 58-9

letter 27(5) 109-13

temazepam prescription patterns 26(4) 78-81

Benztrop

see benztropine 25(6) 147-51

benztropine

Benztrop (New brand) 25(6) 147-51

dystonic reactions 24(1) 19-20

beractant

respiratory distress syndrome - Survanta (New drug) 18(1) 7-9

beta agonists

in asthma 21(1) 22-4

in asthma (letter) 17(2) 28-9

in chronic obstructive pulmonary disease 24(6) 152-5

corticosteroid combination inhalers in asthma 28(2) 26-8

eformoterol - Foradile (New drug) 20(2) 45-51

salmeterol - safety concerns (editorial) 29(5) 118-9

beta blockers

bisoprolol fumarate - heart failure - Bicor (New drug) 25(4) 94-9

distribution in human milk 20(2) 35-40

in early management of myocardial infarction 19(2) 52-4

in glaucoma 25(6) 142-6

in heart failure 23(6) 118-20; 23(6) 120-3

hypertension 30(1) 5-7

letter 30(3) 59-63

metoprolol succinate - Toprol-XL (New formulation) 27(3) 76-9

Betaferon

see interferon beta-1b 25(2) 32-5; 19(1) 24-7

Betagan

see levobunolol 17(4) 87-90

betahistidine

Serc (New strength) 21(2) 49-55

betamethasone

Antroquoril (New brand) 23(1) 21-3

bevacizumab

angiogenesis inhibitors in cancer 29(1) 9-12; 29(1) 13-5

Avastin - colorectal cancer (New drug) 28(4) 104-6

in renal cell cancer 29(6) 151-3

bicalutamide

in prostate cancer (PBAC question) 22(4) 99

prostatic cancer - Cosudex (New drug) 19(4) 108-11

bicarbonates

management of cardiac arrest 20(2) 41-5

Bicor

see bisoprolol fumarate 25(4) 94-9

bile acids

ursodeoxycholic acid - Ursofalk (New drug) 22(4) 95-8

biliary cirrhosis

ursodeoxycholic acid - Ursofalk (New drug) 22(4) 95-8

bimatoprost

glaucoma - Lumigan (New drug) 26(1) 22-3

bioavailability

of generic drugs - PBAC question 23(5) 99

meals and medicines 29(2) 40-2

bioequivalence

generic drugs 30(2) 41-3

letter 30(4) 88-90

generic drugs and drug regulation 26(4) 85-7

letters 26(6) 124-5

Marevan and Coumadin (letter) 30(2) 32-4

bipolar disorders

bipolar I - ziprasidone - Zeldox (New drug) 30(2) 50-55

letter 30(3) 59-63

drug therapy 30(3) 70-3

birth defects

anticonvulsants register 23(2) 43

antidepressants in pregnancy 30(5) 125-7; 18(4) 96

antiepileptics 17(1) 12

biochemical tests in pregnancy 29(2) 48-52

budesonide (letter) 22(3) 53-4

influenza vaccination in pregnancy - information services 24(5) 116-9

isotretinoin in acne 28(3) 59-61

metformin in pregnancy and lactation 30(3) 68-9

thalidomide - erythema nodosum leprosum, multiple myeloma - Thalidomide Pharmion (New drug) 26(6) 146-51

bisoprolol fumarate

heart failure - Bicor (New drug) 25(4) 94-9

bisphosphonates

alendronate - Fosamax (New drug) 19(4) 108-11

alendronate and osteoporosis (PBAC question) 24(2) 41

avascular necrosis of the jaw (letter) 27(2) 28-33

breast cancer 21(1) 15-9

clodronate - Bonefos (New drug) 20(2) 45-51

and osteonecrosis of the jaws 30(4) 96-7

osteoporosis 23(6) 133-6

osteoporosis (letter) 24(3) 51-5

pharmacology 23(6) 130-2

risedronate - osteoporosis, Paget's disease - Actonel (New drug) 24(1) 20-3

tiludronate - Paget's disease - Skelid (New drug) 21(3) 80-3

zoledronic acid - tumour-induced hypercalcaemia - Zometa (New drug) 25(1) 20-3

bites and stings

management of animal and human bites 29(1) 6-8

letters 29(3) 59-62

sea creatures 30(5) 117-21

snake bites 29(5) 125-9

spider bites 29(6) 156-8

bivalirudin

Angiomax - percutaneous coronary intervention (New drug) 28(3) 75-9

bladder, overactive

anticholinergic drugs 29(1) 22-4

letter 29(4) 91-3

darifenacin hydrobromide - Enablex (New drug) 29(5) 138-43

solifenacin succinate - Vesicare - (New drug) 29(5) 138-43

tolterodine - Detrusitol (New drug) 28(2) 49-51

bleeding time

abnormal laboratory results 18(2) 35-8

Blenemax

see bleomycin 24(4) 100-2

bleomycin

Blenemax (New brand) 24(4) 100-2

blepharitis

management 17(3) 66-8

letter 18(2) 27-9

blepharospasm

botulinum toxin - Botox (New drug) 17(1) 6-8

blood coagulation disorders

laboratory results 18(2) 38-41

dental implications 18(2) 48

blood coagulation factors

abnormal haematology results in children 27(3) 64-6

factor VIII inhibitor bypassing fraction - FEIBA-NF - haemophilia (New drug) 30(2) 50-55

recombinant factor IX - haemophilia - Benefix (New drug) 24(3) 71-5

recombinant factor VIIa - NovoSeven (New drug) 22(4) 95-8

recombinant factor VIII - Recombinate (New drug) 19(1) 24-7

thrombophilia and abnormal laboratory results 22(3) 63-6

blood donation

and Rh D immunoglobulin 23(2) 36-8

and RhD immunoglobulin (letter) 24(4) 80-2

blood doping

blood doping 17(4) 78-9

blood gas analysis

and respiratory function tests 23(1) 10-2

blood pressure - see antihypertensives; hypertension

blood pressure monitoring

24-hour ambulatory 20(1) 18-20

blood transfusion

guidelines 28(2) 45-7

and hepatitis C screening 22(4) 91-4

blood volume

pentastarch - hypovolaemia - Voluven (New drug) 30(4) 107-11

bone cancer

clodronate - hypercalcaemia - Bonefos (New drug) 20(2) 45-51

samarium [Sm 153] lexidronam pentasodium - bone metastases - Quadramet (New drug) 21(2) 49-55

bone densitometry

osteoporosis consensus conference 20(4) 82-3

letter 21(2) 31-4

bone fractures

bisphosphonates 23(6) 133-6

bone marrow

methotrexate - adverse effects 23(2) 44-5

letter 23(5) 93-6

bone metabolism

bisphosphonate pharmacology 23(6) 130-2

bone scanning

sulesomab - osteomyelitis diagnosis - LeukoScan (New drug) 25(3) 74-5

Bonefos

see clodronate 20(2) 45-51

Boostrix

see triple antigen 24(4) 100-2

bortezomib

Velcade - multiple myeloma (New drug) 29(3) 84-7

bosentan

pulmonary hypertension - Tracleer (New drug) 26(3) 68-71

Botox

see botulinum toxin 17(1) 6-8

botulinum toxin

blepharospasm - Botox (New drug) 17(1) 6-8

Clostridium botulinum type A toxin - haemagglutinin complex - Dysport (New formulation) 24(2) 43-7

bowel

cancer - risks and hormone replacement therapy 23(5) 90-2

preparation 28(1) 16-7

brain

magnetic resonance imaging in neuroradiology 31(1) 18-20

brain cancer

temozolomide - Temodal (New drug) 23(1) 21

brain diseases

positron emission tomography 18(1) 15-8

brand names

letter 21(2) 31-4

brand price premiums

PBAC question 23(2) 32

breast cancer

anastrozole - Arimidex (New drug) 20(2) 45-51

ancestim - Stemgen (New drug) 23(6) 137-9

letter 24(2) 27-8

antineoplastic antibodies 26(6) 141-3

capecitabine - Xeloda (New drug) 22(4) 95-8

docetaxel - Taxotere (New drug) 19(2) 38-40

drug treatment 21(1) 15-9

dental implications 21(1) 27

exemestane - Aromasin (New drug) 24(3) 71-5

fulvestrant - Faslodex (New drug) 30(4) 107-11

lapatinib - Tykerb (New drug) 30(5) 133-5

letrozole - Femara (New drug) 21(1) 25-7

management of women at risk 25(6) 139-41

risks and hormone replacement therapy 26(1) 8-10; 23(5) 90-2

risks with hormone replacement in menopause (letters) 17(4) 79-81; 17(1) 4-5

taxanes (PBAC question) 30(1) 24-5

toremifene - Fareston (New drug) 21(1) 25-7

trastuzumab - Herceptin (New drug) 24(5) 129-31

vinorelbine - Navelbine (New drug) 21(2) 49-55

letter 21(4) 87-91

breast disease

and disodium pamidronate (letter) 22(2) 28-31

breastfeeding

antidepressants 30(5) 125-7

antipsychotics 30(6) 162-3

dental implications 20(2) 51

'Drugs and breastfeeding' (book review) 27(6) 154

metronidazole (letter) 28(2) 29-33

drugs in human milk 20(2) 35-40

letters 21(4) 87-91; 21(2) 31-4; 21(1) 5-8; 20(4) 83-6

metformin and diabetes 30(3) 68-9

pethidine in labour pain 27(2) 34-5

Brenda-35 ED

see cyproterone 20(1) 22-3

brimonidine

in glaucoma 25(6) 142-6

glaucoma - Alphagan (New drug) 22(2) 43-7

brinzolamide

in glaucoma 25(6) 142-6

glaucoma - Azopt (New drug) 24(2) 43-7

bromocriptine

in Parkinson's disease 17(1) 21-3

bronchitis

Antibiotics 19(2) 48-51

bronchodilators

asthma inhalation devices 26(1) 5-7

letter - tropical climates 26(4) 75-7

in chronic obstructive pulmonary disease 30(3) 64-7; 26(2) 33-5; 24(6) 152-5

letter - alpha-1-antitrypsin deficiency 30(6) 140-41

tiotropium bromide - chronic obstructive pulmonary disease - Spiriva (New drug) 26(1) 22-3

bruxism

psychotropic drugs and dentistry 30(4) 98-101

B-type natriuretic peptide

congestive heart failure - abnormal laboratory results 26(3) 64-5

Bucanest

see articaine 28(1) 19-23

budesonide

combination inhalers in asthma 28(2) 26-8

corticosteroid therapy in asthma 29(3) 63-6

Crohn's disease - Entocort (New formulation) 22(1) 20-3

in croup 20(4) 99-101

in pregnancy (letter) 22(3) 53-4

budgeting

letter 20(4) 83-6

prescribing budgets (editorials) 20(2) 28-9; 20(2) 30-1

bulimia

eating disorders - the patient's perspective 21(4) 103-5

management 21(4) 100-3

letter 22(3) 53-4

patient support organisations 21(4) 105

bupivacaine enantiomer

levobupivacaine - anaesthetic - Chirocaine (New drug) 24(5) 129-31

buprenorphine

opiate dependence - Subutex (New drug) 24(3) 71-5

correction 24(5) 129-31

in opioid dependence 24(1) 4-6

bupropion

heavy demand from smokers (PBAC question) 24(3) 64

nicotine dependence - Zyban (New drug) 24(1) 20-3

butoconazole nitrate

Gynazole - candidal vulvovaginitis (New drug) 29(5) 138-43

Byetta

see exenatide 30(6) 163-7

Home

Useful Links

Privacy

Web Manager



	Home About Us Contact Us Index Search Consumer Topics Back Issues